Sales enablement works, and the numbers are unambiguous: organizations with a structured enablement strategy see 84% of reps hit quota, close marketing-sourced leads 67% more often, and claw back hundreds of selling hours lost to hunting for content. Below are 16 statistics that make the business case, grouped by what they prove — each with its source named, so you can trace every number.
The business case: quota and revenue
- 84% of sales reps achieve quota at companies with a best-in-class sales enablement strategy — versus roughly 55% elsewhere. (Aberdeen Group)
- Marketing-generated leads are 67% more likely to close when sales and marketing teams are aligned. (Marketo)
- Aligned organizations achieve 208% higher marketing revenue than misaligned ones. (MarketingProfs)
- Best-in-class enablement drives a ~14% lift in annual contract value and average deal size. (Aberdeen Group)
- 55% of C-suite executives name sales enablement solutions as the top technology investment for boosting sales productivity. (CSO Insights)
- Quota attainment improved 10.6 points (a 22.7% relative gain) at organizations with a formal enablement function. (CSO Insights, Sales Enablement Report)
The cost of doing nothing: content waste
- 90% of B2B sellers don’t use their sales material because it is irrelevant, outdated, or difficult to customize. (Forrester)
- About 65% of marketing content goes unused by the sales team it was made for. (SiriusDecisions)
- 65% of reps say they can’t find content worth sending to prospects — the most common complaint among US sales teams. (Kapost)
- Unused content costs enterprises ~$2.3 million a year in opportunity cost alone. (SiriusDecisions)
- Reps spend ~440 hours a year hunting for content — eleven working weeks of searching instead of selling. (Seismic/Forbes)
- Sales and marketing misalignment costs businesses $1 trillion a year in lost productivity and wasted marketing spend. (HubSpot)
The rep’s reality: time and buyers
- Reps spend only ~37% of their time on revenue-generating activities. The rest goes to admin, searching, and internal work. (InsideSales.com)
- Only 34% of organizations tailor content to their target industries — a gap that matters double in regulated fields like medtech. (CSO Insights)
- 76% of customers expect companies to understand their needs and expectations before the first conversation. (Salesforce, State of the Connected Customer)
Where it’s going
- 90% of companies have implemented AI in their go-to-market motion or plan to this year. Enablement platforms are where that AI meets the field rep. (Highspot, State of Sales Enablement 2025)
How to read these numbers
Two honest caveats. First, the classics here (Aberdeen, CSO Insights, Forrester, SiriusDecisions) date from the 2016–2019 research wave — the era that established the category. The directional findings have been replicated repeatedly since, but treat precise percentages as benchmarks, not gospel. Second, most of this research covers B2B sales broadly. In medical device sales enablement, the content-waste numbers run worse: reps sell in hospitals and ORs where connectivity fails, compliance restricts what marketing can ship, and distributor reps often never see the content at all — which is why offline access and governed distributor sharing move these numbers more in medtech than any other single fix.
If you’re building the case internally, start with what sales enablement is and the benefits of sales enablement and how platforms differ, then put the categories head-to-head on the comparison hub. SoloFire’s approach: content, branded Spaces, SCORM training, and AI coaching in one app your field team will actually use — $30 per user per month, everything included.
Frequently asked questions
What is the most-cited sales enablement statistic?
The 84% quota-attainment figure from Aberdeen Group: 84% of reps hit quota at companies with best-in-class sales enablement, versus roughly 55% at companies without a structured program.
Do these statistics apply to medical device sales?
Directionally yes, but the content-waste problem is worse in medtech: offline environments (hospitals, ORs), regulatory limits on materials, and distributor channels that generic platforms don’t reach. That’s why medtech-specific platforms outperform horizontal suites on these metrics.
What ROI should a sales enablement program show?
The research points to three measurable lifts: quota attainment (84% vs ~55%), deal size (~14% higher ACV), and selling time recovered (up to 440 hours per rep per year previously lost to content hunting).